mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK.
about
Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.MicroRNAs Correlate with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in a Chinese Population.A miRNA-101-3p/Bim axis as a determinant of serum deprivation-induced endothelial cell apoptosis.Long non-coding RNA NEAT1 regulates epithelial membrane protein 2 expression to repress nasopharyngeal carcinoma migration and irradiation-resistance through miR-101-3p as a competing endogenous RNA mechanism.The Glycolytic Switch in Tumors: How Many Players Are Involved?Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.Frankincense, pine needle and geranium essential oils suppress tumor progression through the regulation of the AMPK/mTOR pathway in breast cancer.CMIP is oncogenic in human gastric cancer cells.Co-expression analysis revealed PTCH1-3'UTR promoted cell migration and invasion by activating miR-101-3p/SLC39A6 axis in non-small cell lung cancer: implicating the novel function of PTCH1.MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer.MiR-101-3p Regulates the Viability of Lung Squamous Carcinoma Cells via Targeting EZH2.
P2860
Q33602610-5590AA1E-3975-493F-83CB-FCEBBA7D9F6BQ33763366-9B1C83D0-0A72-4050-BE31-49C616F43879Q41082774-C46B8CF9-8172-4ED2-8B4D-BF5A77E995F6Q42378413-E45B1EE7-C59B-4FEB-A9A5-354C094342E7Q45419184-BD317838-DA73-43A7-B82E-958B9D64A20DQ47394844-E304D308-0750-4F39-B7C2-A7D6A2784190Q47634621-C04BE7D8-5E01-42D9-AABD-A5880CAADC55Q47749695-80859F7E-C842-440F-AFA3-A22A4A4D7446Q49613127-A59B9A8A-48A6-43B5-84D0-EC097D34DE7EQ50354652-DA7249AF-C01B-4BB9-90BF-955D14E6BD57Q51267160-7E1DF2C2-4D20-4C69-9860-D7BDC201EE4E
P2860
mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
mir-101-3p is a key regulator ...... breast cancer targeting AMPK.
@en
mir-101-3p is a key regulator ...... breast cancer targeting AMPK.
@nl
type
label
mir-101-3p is a key regulator ...... breast cancer targeting AMPK.
@en
mir-101-3p is a key regulator ...... breast cancer targeting AMPK.
@nl
prefLabel
mir-101-3p is a key regulator ...... breast cancer targeting AMPK.
@en
mir-101-3p is a key regulator ...... breast cancer targeting AMPK.
@nl
P2093
P2860
P356
P1433
P1476
mir-101-3p is a key regulator ...... breast cancer targeting AMPK.
@en
P2093
Cailu Song
Hailin Tang
Shuaijie Li
Weidong Wei
Xiaojia Huang
Xiaoming Xie
Xinhua Xie
P2860
P304
35188-35198
P356
10.18632/ONCOTARGET.9072
P407
P577
2016-04-28T00:00:00Z